Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies

KH Katsanos, K Papamichael, JD Feuerstein… - Clinical …, 2019 - Elsevier
The pharmacological management of inflammatory bowel disease (IBD) over the last two
decades has transitioned from reliance on aminosalycilates, corticosteroids and …
被引用次数：96 相关文章

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies

KH Katsanos, K Papamichael… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
The pharmacological management of inflammatory bowel disease (IBD) over the last two
decades has transitioned from reliance on aminosalycilates, corticosteroids and …

Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies.

KH Katsanos, K Papamichael… - Clinical Immunology …, 2018 - europepmc.org
The pharmacological management of inflammatory bowel disease (IBD) over the last two
decades has transitioned from reliance on aminosalycilates, corticosteroids and …

[引用][C] Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies

KH Katsanos, K Papamichael, JD Feuerstein… - Clinical …, 2019 - cir.nii.ac.jp
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …